Breastcancerneoadjuvantchemotherapy

由 M Asaoka 著作 · 2020 · 被引用 79 次 — Neoadjuvant chemotherapy regimen consisted of doxorubicin, paclitaxel, cyclophosphamide, methotrexate, and fluorouracil. Disease-free survival ...

由 LA Korde 著作 · 2021 · 被引用 476 次 — Neoadjuvant therapy was initially used in breast cancer for the treatment of inoperable, locally advanced disease. Subsequently, the role of ...

由 O Ortmann 著作 · 2023 · 被引用 13 次 — Neoadjuvant chemotherapy (NACT) for breast cancer was initially introduced to treat locally advanced disease to make it more accessible for ...

2023年12月6日 — Treatment de-escalation may be an option for patients whose lymph nodes become cancer free after neoadjuvant treatment.

2022年11月9日 — Neoadjuvant chemotherapy for breast cancer is typically given before your main treatment, which is usually surgery. In some cases, neoadjuvant ...

由 S Masood 著作 · 2016 · 被引用 127 次 — Currently, neoadjuvant chemotherapy is offered to patients with locally advanced breast cancer and also those breast cancer patients who may benefit from size ...

由 AM Thompson 著作 · 2012 · 被引用 276 次 — Neoadjuvant chemotherapy regimens most commonly contain an anthracycline (adriamycin or epirubicin) in combination or sequentially administered with taxanes ( ...

由 WM Sikov 著作 · 被引用 7 次 — Neoadjuvant therapy refers to the systemic treatment of breast cancer prior to definitive surgical therapy (ie, preoperative therapy).

由 A Bardia 著作 — Choice of neoadjuvant chemotherapy for HER2-negative breast cancer ... Neoadjuvant therapy for patients with HER2-positive breast cancer ...